Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
International Immunopharmacology|September 9, 2025
Therapeutic potentials of mesenchymal stem cells and their extracellular vesicles on liver diseases by modulating mitochondrial function of macrophagesShouhan Yao, Yelei Cen, Guohua Lou, et al.Cell Communication and Signaling : CCS|August 18, 2023
A new perspective on mesenchymal stem cell-based therapy for liver diseases: restoring mitochondrial functionYelei Cen, Guohua Lou, Jinjin Qi, et al.Antioxidants (Basel, Switzerland)|January 21, 2023
Adipose-Derived Mesenchymal Stem Cells Inhibit JNK-Mediated Mitochondrial Retrograde Pathway to Alleviate Acetaminophen-Induced Liver InjuryYelei Cen, Guohua Lou, Jinjin Qi, et al.International Immunopharmacology|January 10, 2026
Monocrotaline induces liver injury via TRX1-ASK1-JNK Axis-mediated mitochondrial damage in hepatocytesCaixia Xia, Yelei Cen, Shouhan Yao, et al.American Journal of Physiology. Cell Physiology|June 27, 2023
Decreased miR-17-92 cluster correlates with senescence features, disrupted oxidative homeostasis, and impaired therapeutic efficacy of mesenchymal stem cellsYelei Cen, Jinjin Qi, Liang Chen, et al.Cell & Bioscience|January 8, 2021
Selonsertib, a potential drug for liver failure therapy by rescuing the mitochondrial dysfunction of macrophage via ASK1-JNK-DRP1 pathwayGuohua Lou, Aichun Li, Yelei Cen, et al.Stem Cell Research & Therapy|November 23, 2025
Adipose-derived mesenchymal stem cell therapy modulates mitochondrial function to attenuate acetaminophen-induced liver injury by DDIT4/PGC-1α axisYelei Cen, Caixia Xia, Shouhan Yao, et al.Pageof 1